His primary areas of investigation include CD40, Molecular biology, Immunology, Cytokine and T cell. His CD40 research is multidisciplinary, relying on both Immunoglobulin class switching, Secretion, Antigen and Antibody, Monoclonal antibody. William C. Fanslow interconnects Chemokine, ULBP1 and Cell biology in the investigation of issues within Antigen.
He combines subjects such as Receptor, Interleukin-21 receptor, Interleukin-17 receptor and CD30 with his study of Molecular biology. His research in Immunology is mostly concerned with Immune system. His studies deal with areas such as Complementary DNA and Peptide sequence as well as T cell.
His scientific interests lie mostly in CD40, Molecular biology, Antibody, Immunology and Biochemistry. His CD40 study combines topics from a wide range of disciplines, such as Cell culture, Cancer research, Antigen, B cell and Monoclonal antibody. His work carried out in the field of Molecular biology brings together such families of science as T cell, Interleukin 21, Receptor, Peptide sequence and Interleukin-4 receptor.
William C. Fanslow studied T cell and Cytotoxic T cell that intersect with Cell biology and CD8. His Antibody research is multidisciplinary, incorporating perspectives in Mutation, Polynucleotide and Virology. In his research, In vitro and Stimulation is intimately related to In vivo, which falls under the overarching field of Immunology.
William C. Fanslow mainly investigates Antibody, Angiogenesis, Biochemistry, Immunology and Molecular biology. The concepts of his Antibody study are interwoven with issues in Receptor, Cell, Polynucleotide and Pharmacology. His Immunology research incorporates elements of Interleukin-21 receptor and Cell biology.
William C. Fanslow studied Cell biology and Antigen that intersect with Immunotherapy, Hyper IgM syndrome, Interferon gamma, CD40 and Immune system. The various areas that William C. Fanslow examines in his Molecular biology study include Pharmacokinetics, In vitro, Immunoglobulin G, Recombinant CD40-Ligand and X-Linked Hyper IgM Syndrome. His Epitope study incorporates themes from Nectin, Cytotoxic T cell, T cell, Antigen-presenting cell and Function.
The scientist’s investigation covers issues in Antibody, Antigen, Cell culture, Immunology and Cell. His studies in Antibody integrate themes in fields like Molecular biology and Receptor. The Molecular biology study combines topics in areas such as Immunoglobulin G, Immunoglobulin Fc Fragments, Antibody-dependent cell-mediated cytotoxicity, Fragment crystallizable region and Effector.
Nectin is closely connected to Cell biology in his research, which is encompassed under the umbrella topic of Antigen. His work on Immunology is being expanded to include thematically relevant topics such as CD40. William C. Fanslow has researched Cell in several fields, including Cell-mediated cytotoxicity, Mouse xenograft, Tumor growth, Transfection and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor
David Cosman;Jürgen Müllberg;Claire L. Sutherland;Wilson Chin.
Immunity (2001)
Human IL-17: a novel cytokine derived from T cells.
Zhengbin Yao;S. L. Painter;W. C. Fanslow;D. Ulrich.
Journal of Immunology (1995)
Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor.
Zhengbin Yao;William C. Fanslow;Michael F. Seldin;Anne Marie Rousseau.
Immunity (1995)
Molecular and biological characterization of a murine ligand for CD40
Richard J. Armitage;William C. Fanslow;Laura Strockbine;Timothy A. Sato.
Nature (1992)
CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome
R. Cutler Allen;Richard J. Armitage;Mary Ellen Conley;Howard Rosenblatt.
Science (1993)
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF
Craig A. Smith;Hans Juergen Gruss;Terri Davis;Dirk Anderson.
Cell (1993)
A Novel TNF Receptor Family Member Binds TWEAK and Is Implicated in Angiogenesis
Steven R Wiley;Linda Cassiano;Timothy Lofton;Terry Davis-Smith.
Immunity (2001)
Evidence for a Role of IL-17 in Organ Allograft Rejection: IL-17 Promotes the Functional Differentiation of Dendritic Cell Progenitors
Mary A. Antonysamy;William C. Fanslow;Fumin Fu;Wei Li.
Journal of Immunology (1999)
Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor.
Raymond G. Goodwin;Wenie S. Din;Terri Davis-Smith;Dirk M. Anderson.
European Journal of Immunology (1993)
CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania major
Kim A Campbell;Pamela J Ovendale;Mary K Kennedy;William C Fanslow.
Immunity (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Amgen (United States)
Amgen (United States)
Corixa Corporation
Texas A&M University
Harvard University
Amgen (United States)
Vanderbilt University
George Washington University
Virginia Mason Medical Center
University of Saskatchewan
University of Pennsylvania
Cornell University
IBM (United States)
Aix-Marseille University
University of Duisburg-Essen
Spanish National Research Council
Wageningen University & Research
University of Technology Sydney
Spanish National Research Council
Freie Universität Berlin
Kansas State University
University of North Carolina at Chapel Hill
AstraZeneca (United Kingdom)
York University
Nanjing University
Peking University